Deutsche Bank Upgrades Persimmon to Buy After Strong First-Half Results 
JPMorgan Plans More Asia-Pacific Hiring in 2027 as Corporate Banking Revenue Surges 
Nvidia Seen Beating Q2 Targets as Vera Rubin Cycle Begins 
Nvidia Secures $500 Billion AI Infrastructure Push With Wall Street Giants 
ADNOC Gas Targets Up to $4B Profit in 2026 
Shein Scales Back Vietnam Operations as US Trade Rules Shift 
Austal Shares Surge 16% as Hanwha Offers Up to $1.2 Billion for U.S. Shipbuilding Business 
UOB Q2 Net Profit Rises 10% as Wealth Management Growth Boosts Earnings 
Daimler Truck Q2 Profit Falls 18%, 2026 Outlook Raised 
Anthropic Signs $9.1B AI Data Center Deal With Riot Platforms 
Apple Tests China’s CXMT Memory Chips for iPhones and MacBooks Amid AI Supply Crunch 
Mercedes-Benz Stock Offers Deep-Value Potential as Citi Sees Recovery Catalysts 
Delta Flight Makes Emergency Landing in Atlanta After Cockpit Fumes Reported 
Airbus Joins Air India A320 Altitude Drop Probe 
AMP Shares Surge 13% After Strong Profit and A$150 Million Buyback 
Goldman Sachs Sees US Stock Buybacks Outpacing Equity Issuance as AI Funding Rises 
Alibaba Plans Revenue-Sharing Model for Qwen3.8-Max AI Commercial Users 
TAIPEI, Taiwan, Feb. 17, 2018 -- Taiwan Liposome Company, Ltd. (4152.TWO) (TLC), a clinical-stage specialty pharmaceutical company dedicated to the development and commercialization of novel nanomedicines designed to target areas of medical need in pain management, ophthalmology, and oncology, today announced that it has filed a registration statement on Form F-1 with the U.S. Securities and Exchange Commission (SEC) relating to a proposed initial public offering in the United States of its American Depositary Shares (ADSs) representing shares of common stock. All ADSs to be sold in the offering will be offered by TLC. The number of ADSs to be offered and the price for the proposed offering have not yet been determined. TLC has applied to list its ADSs on The Nasdaq Global Market under the trading symbol "TLC".
Cantor Fitzgerald & Co. is acting as the sole book-running manager for the offering. CLSA Limited, H.C. Wainwright & Co., LLC, Janney Montgomery Scott LLC, and Laidlaw & Company (UK) Ltd. are acting as co-managers.
The proposed offering will be made only by means of a prospectus. A copy of the preliminary prospectus, when available, may be obtained from Cantor Fitzgerald & Co., Attention: Capital Markets, 499 Park Avenue, 6th Floor New York, New York 10022; Email: [email protected].
A registration statement relating to these securities has been filed with the SEC but has not yet become effective. These securities may not be sold, nor may offers to buy be accepted, prior to the time the registration statement becomes effective. This press release shall not constitute an offer to sell or the solicitation of an offer to buy, nor shall there be any sale of these securities in any state or jurisdiction in which such offer, solicitation, or sale would be unlawful prior to registration or qualification under the securities laws of any such state or jurisdiction.
Contact:
Dawn Chi
Corporate Communications
Tel: +886 (0)2 2655 7377 ext 136
Email: [email protected]
